出处
《实用医学杂志》
CAS
2006年第9期1086-1088,共3页
The Journal of Practical Medicine
基金
广东省医学科研基金立项项目(编号:A2005505)
参考文献25
-
1CLIFTON M A. Familial abdominal aortic aneurysms [J]. Br J Surg, 1977,64( 11 ) :765 - 766.
-
2TILSON M D, SEAHORE M R. Fifty families with abdominal aortic aneurysms in two or more first order relatives [J]. Am J Surg, 1984,147(4) :551 -553.
-
3POWELL J T, BASHIR A, DAWSON S, et al. Genetic variation on chromsosome 16 is associated with abdominal aortic aneurysm[J]. Clin Sci, 1990,78(1):132.
-
4VOLLMAR J F, PAES E, PAUSCHINGER P, et al. Aortic aneurysms as late sequelae of above-knee amputation [J]. Lancet,1989,2(8667) :834 - 835.
-
5FREESTONE T, TURNER R J, COADY A, et al. Inflammation and matrimetallo proteinases in the enlarging abdominal aortic aneurysm [J] . Arterioscler Thromb Vase Biol, 1995,15 (8) : 1145.
-
6NACKMAN G B, KARKOWSKI F J,HALPERN V J, et al. Elastin degradatio products induce adventitial angiogenesisin the Anidjar/Dobrinrat aneurysm model[J]. Surgery, 1997,122(1) :39 - 44.
-
7ALLAIRE E, FOROUGH R, CLOWES M,et al. Local over expression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model [J]. J Clin Invest,1998,102(7) :1413.
-
8WHITE J V, HAAS K, COMEROTA A J.Adventitial elastolysis is a primar event in aneurysms formation [J]. J Vase Surg,1993,17 (2) :371.
-
9HALPERN V J, NSCKMAN G B, GRANDI R H, et al. The elastase infusion model of experimental aortic aneurysm model:Synchronyof induction of endogenous proteinases with matrix destruction and inflammatory cell response [J]. J Vasc Surg, 1994,20 ( 1 ) : 51 - 60.
-
10SZEKANECZ Z, SHAH M R, PEARCE W H, et al. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation[J]. Agents Actions, 1994, 42(3/4):159 -162.
同被引文献47
-
1倪松,郑月宏,管珩.基质金属蛋白酶在腹主动脉瘤形成中的作用研究进展[J].中国普通外科杂志,2004,13(8):619-621. 被引量:6
-
2董少红,温隽珉,罗林杰,陈科奇,梁新剑,李宜富,刘华东,陈焕展,黄志昕.大剂量阿托伐他汀对急性冠状动脉综合征的调脂及抗炎作用[J].中国动脉硬化杂志,2006,14(7):613-616. 被引量:15
-
3Lindholt JS, Shi GP. Chronic inflammation, immune response, and infection in abdominal aortic aneurysms [ J ]. Eur J Vasc Endovasc Surg, 2006 , 31 ( 5 ) : 453 - 463.
-
4Raffeiner B , Dejaco C, Duftner C , et al. Between adaptive and innate immunity: TLR4-mediated perforin production by CD28 null T-helper cells in ankylosing spondylitis [ J ] . Arthritis Res Ther, 2005,7(6) :R1412 - 1420.
-
5Viardot A, Grey ST, Mackay F, et al. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype [J]. Endocrinology, 2007,148(1 ) :346 -353.
-
6Fasth AE , Cao D , van Vollenhoven R , et al. CD28nullCD4 + T cells-characterization of an effector memory T-cell population in patients with rheumatoid arthritis [ J ] . Scand J Immunol, 2004,60(1 -2) :199 -208.
-
7Kuivaniemi H, Platsoucas CD, Tilson MD 3 rd. Aortic aneurysms : an immune disease with a strong genetic cornponenl [J]. Circulation,2008,117(2) :242 -252.
-
8Tsuruda T, Kato J, Hatakeyama K, et al. Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm [ J ] Circ Res, 2008, 102 ( 11) : 1368 - 1377.
-
9Singh K,Bonaa KH,Jacobsen BK,et al. Prevalence of andfisk factors for abdominal aortic aneurysms in a population-based study: The Tromso Study[ J]. Am J Epidemio1,2001 ; 154 ( 3 ) :236-44.
-
10O'Rourke M, Fochlich ED. Pulse pressure is this a clinically, useful risk factor[ J]. Hypretension, 1999 ;34:372-4.
引证文献7
-
1黄惠平,李国瑞,苏丽雅,汪振荣,吴惠萍.老年腹主动脉病变的彩色多谱勒超声表现与危险因素分析[J].中国老年学杂志,2008,28(13):1319-1320.
-
2许文平,邱健,李志梁,谢志泉,何柏身,梁爱琼.阿托伐他汀抑制腹主动脉瘤基质金属酶9及核因子κB表达的实验研究[J].中国动脉硬化杂志,2008,16(8):600-602. 被引量:9
-
3许文平,李志樑,邱健,谢志泉.腹主动脉瘤患者外周血CD4^+ CD28^-调节性T细胞的变化及意义[J].中国普通外科杂志,2011,20(6):651-654. 被引量:7
-
4许文平,李志樑,邱健,谢志泉.腹主动脉瘤患者CD4^+ CD28^- T淋巴细胞及Th1细胞因子的变化及临床意义[J].中国动脉硬化杂志,2012,20(12):1117-1120. 被引量:2
-
5许文平,谢志泉,李志樑,邱健,吴自强,傅锐斌.大鼠腹主动脉瘤形成过程中T细胞及CD4+CD28-T细胞的动态变化及意义[J].中华普通外科杂志,2013,28(4):296-299. 被引量:2
-
6武亚丽,周洪莲,郑红波,童雪影.整合素β_3在大鼠腹主动脉瘤中的表达及意义[J].中国动脉硬化杂志,2013,21(7):609-613. 被引量:1
-
7喻婵,王卓,李稳磊,张炽明,朱瑶瑶,任建聪,林忠伟.Fibulin-3在腹主动脉瘤中的表达[J].实用医学杂志,2020,36(15):2094-2098. 被引量:4
二级引证文献23
-
1黎东华,李浪.他汀类药物对动脉粥样硬化抗炎作用机制的新进展[J].中国动脉硬化杂志,2009,17(5):417-420. 被引量:13
-
2谢遥,程晓曙.肿瘤坏死因子样凋亡微弱诱导剂与动脉粥样硬化[J].中国动脉硬化杂志,2010,18(6):412-414. 被引量:2
-
3王蕾蕾,王国贤.水飞蓟素对糖尿病大鼠心肌损伤的保护作用[J].中国动脉硬化杂志,2010,18(8):625-629. 被引量:5
-
4王海燕,朱中生.金属硫蛋白和瑞舒伐他汀对APOE基因缺失小鼠主动脉核因子-κB表达的影响[J].现代中西医结合杂志,2011,20(3):282-284.
-
5许文平,李志樑,邱健,谢志泉.腹主动脉瘤患者外周血CD4^+ CD28^-调节性T细胞的变化及意义[J].中国普通外科杂志,2011,20(6):651-654. 被引量:7
-
6康雅萍,王国贤,魏小刚.α-硫辛酸对糖尿病大鼠心肌病保护作用[J].中国公共卫生,2012,28(1):48-50. 被引量:3
-
7罗赛华,戴世学,梁仔,肖绍文,郭赛群,阮玉山,邱兵.颅内动脉瘤破裂与CD8^+CD28^-调节性T细胞的关系[J].中国神经精神疾病杂志,2012,38(7):425-427. 被引量:4
-
8许文平,李志樑,邱健,谢志泉.腹主动脉瘤患者CD4^+ CD28^- T淋巴细胞及Th1细胞因子的变化及临床意义[J].中国动脉硬化杂志,2012,20(12):1117-1120. 被引量:2
-
9梁仔,罗赛华.不同级别胶质瘤患者CD8+CD28-抑制性T细胞的表达与临床意义[J].立体定向和功能性神经外科杂志,2012,25(6):342-344. 被引量:3
-
10陈英.动脉粥样斑块与MMP、CD40关系及他汀类药物作用机理的研究进展[J].内科,2013,8(1):63-65. 被引量:1
-
1蔡滨宁,方桂云.心肌梗塞的内科治疗进展[J].黑龙江医药,1999,12(5):277-280.
-
2宋小宁,杨岫岩.类风湿关节炎的内科治疗进展[J].广州医药,1997,28(1):4-6.
-
3王泽民.肝硬化腹水内科治疗进展[J].长风科技,1991(2):41-47.
-
4李亮成.急性胰腺炎内科治疗进展[J].中国医刊,2000,35(6):2-3. 被引量:10
-
5沈国钧.门脉高压症的发病机理及内科治疗进展[J].江苏医药,1992,18(2):107-110. 被引量:1
-
6陈平,袁耀宗.重症急性胰腺炎的内科治疗进展[J].临床消化病杂志,2006,18(1):6-8. 被引量:7
-
7狩野庄吾,王春生.变态反应、胶原病、免疫异常[J].日本医学介绍,1989,10(12):529-530.
-
8韦春秋.重症急性胰腺炎的内科治疗进展[J].中外医疗,2010,29(26):23-24. 被引量:2
-
9杨秀疆,陈士葆.肝炎后肝硬化内科治疗进展[J].世界感染杂志,2002,2(3):190-193. 被引量:3
-
10汤美安.类风湿关节炎的内科治疗进展[J].新医学,1996,27(4):172-173. 被引量:3